BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4777712)

  • 1. Mechanisms contributing to barbiturate intolerance in rats.
    Aston R
    Br J Pharmacol; 1973 Nov; 49(3):527-33. PubMed ID: 4777712
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The sensitivity of the brain to barbiturate during chronic administration and withdrawal of barbitone sodium in the rat.
    Stevenson IH; Turnbull MJ
    Br J Pharmacol; 1970 Jun; 39(2):325-33. PubMed ID: 5463901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of the factors affecting the sleeping time following intracerebroventricular administration of pentobarbitone sodium: effect of prior administration of centrally active drugs.
    Stevenson IH; Turnbull MJ
    Br J Pharmacol; 1974 Apr; 50(4):499-511. PubMed ID: 4155651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute tolerance to barbiturate in the rat.
    Turnbull MJ; Watkins JW
    Eur J Pharmacol; 1976 Mar; 36(1):15-20. PubMed ID: 944131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Barbitone-induced tolerance to the effects of sedative-hypnotics and related compounds on operant behaviour in the rat.
    Carney JM; Rosecrans JA; Vasko MR
    Br J Pharmacol; 1979 Feb; 65(2):183-92. PubMed ID: 760896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of tricyclic antidepressants and barbiturates in barbiturate-tolerant and nontolerant rats.
    Liu SJ; Huang CL; Waters IW
    J Pharmacol Exp Ther; 1975 Aug; 194(2):285-95. PubMed ID: 1151759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of chronic barbitone administration and withdrawal on the sensitivity of the central nervous system to barbiturate.
    Stevenson IH; Turnbull MJ
    Br J Pharmacol; 1969 Oct; 37(2):502P-503P. PubMed ID: 5388578
    [No Abstract]   [Full Text] [Related]  

  • 8. The effects of oestrogens and progestins on the response of mice to barbiturates.
    Blackham A; Spencer PS
    Br J Pharmacol; 1969 Sep; 37(1):129-39. PubMed ID: 5360338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Barbital-induced cross-tolerance to barbiturates by the intracisternal route of administration.
    Stolman S; Loh HH
    Res Commun Chem Pathol Pharmacol; 1975 Oct; 12(2):309-16. PubMed ID: 1197916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Barbiturate-induced choleresis: possible independence from microsomal enzyme induction.
    Capron JP; Dumont M; Feldmann G; Erlinger S
    Digestion; 1977; 15(6):556-65. PubMed ID: 913919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of caffeine on barbiturate sleeping time and brain level.
    Aeschbacher HU; Atkinson J; Domahidy B
    J Pharmacol Exp Ther; 1975 Mar; 192(3):635-41. PubMed ID: 1120961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of prenylamine pretreatment on barbiturate sleeping time in rats.
    Saraf AP; Joglekar GV
    Indian J Exp Biol; 1973 May; 11(3):232-3. PubMed ID: 4782625
    [No Abstract]   [Full Text] [Related]  

  • 13. A model for the rapid induction of barbiturate tolerance.
    Mann PA; Isom GE
    Proc West Pharmacol Soc; 1978; 21():387-90. PubMed ID: 693521
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased tolerance in mice following prenatal exposure to barbiturate.
    Yanai J; Tabakoff B
    Psychopharmacology (Berl); 1979 Sep; 64(3):325-7. PubMed ID: 116275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerance experiments with barbitone-dependent rats.
    Turnbull MJ; Stevenson IH
    J Pharm Pharmacol; 1968 Nov; 20(11):884-5. PubMed ID: 4387501
    [No Abstract]   [Full Text] [Related]  

  • 16. Hexobarbital (enhexymalum NFN) sleeping times and EEG threshold doses as measurements of tolerance to barbiturates in the rat.
    Wahlström G
    Acta Pharmacol Toxicol (Copenh); 1968; 26(1):64-80. PubMed ID: 5694267
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolongation of barbiturate-induced sleeping time in mice by dimethylformamide (DMF) and other non-polar solvents: absence of an effect on hepatic barbiturate-metabolising enzymes.
    Weetman DF; Crossfield C
    Methods Find Exp Clin Pharmacol; 1982; 4(2):99-103. PubMed ID: 7121125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of functional tolerance during barbiturate physical dependency production.
    Okamoto M; Boisse NR; Rosenberg HC; Rosen R
    J Pharmacol Exp Ther; 1978 Dec; 207(3):906-15. PubMed ID: 569696
    [No Abstract]   [Full Text] [Related]  

  • 19. Some observations on the mechanism of benzodiazepine-barbiturate interactions in the mouse.
    Chambers DM; Jefferson GC
    Br J Pharmacol; 1977 Jul; 60(3):393-9. PubMed ID: 19117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in serotonin turnover and the brain sensitivity to barbiturates by disulfiram treatment in rats.
    Minegishi A; Fukumori R; Satoh T; Kitagawa H; Yanaura S
    Res Commun Chem Pathol Pharmacol; 1979 May; 24(2):273-87. PubMed ID: 461985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.